241 related articles for article (PubMed ID: 12074974)
21. Resveratrol as a chemopreventive agent: a promising molecule for fighting cancer.
Delmas D; Lançon A; Colin D; Jannin B; Latruffe N
Curr Drug Targets; 2006 Apr; 7(4):423-42. PubMed ID: 16611030
[TBL] [Abstract][Full Text] [Related]
22. Inhibitory effect of citrus 5-hydroxy-3,6,7,8,3',4'-hexamethoxyflavone on 12-O-tetradecanoylphorbol 13-acetate-induced skin inflammation and tumor promotion in mice.
Lai CS; Li S; Chai CY; Lo CY; Ho CT; Wang YJ; Pan MH
Carcinogenesis; 2007 Dec; 28(12):2581-8. PubMed ID: 17962218
[TBL] [Abstract][Full Text] [Related]
23. Pterostilbene is equally potent as resveratrol in inhibiting 12-O-tetradecanoylphorbol-13-acetate activated NFkappaB, AP-1, COX-2, and iNOS in mouse epidermis.
Cichocki M; Paluszczak J; Szaefer H; Piechowiak A; Rimando AM; Baer-Dubowska W
Mol Nutr Food Res; 2008 Jun; 52 Suppl 1():S62-70. PubMed ID: 18551458
[TBL] [Abstract][Full Text] [Related]
24. Cancer chemopreventive and antioxidant activities of pterostilbene, a naturally occurring analogue of resveratrol.
Rimando AM; Cuendet M; Desmarchelier C; Mehta RG; Pezzuto JM; Duke SO
J Agric Food Chem; 2002 Jun; 50(12):3453-7. PubMed ID: 12033810
[TBL] [Abstract][Full Text] [Related]
25. Resveratrol causes WAF-1/p21-mediated G(1)-phase arrest of cell cycle and induction of apoptosis in human epidermoid carcinoma A431 cells.
Ahmad N; Adhami VM; Afaq F; Feyes DK; Mukhtar H
Clin Cancer Res; 2001 May; 7(5):1466-73. PubMed ID: 11350919
[TBL] [Abstract][Full Text] [Related]
26. Substituted trans-stilbenes, including analogues of the natural product resveratrol, inhibit the human tumor necrosis factor alpha-induced activation of transcription factor nuclear factor kappaB.
Heynekamp JJ; Weber WM; Hunsaker LA; Gonzales AM; Orlando RA; Deck LM; Jagt DL
J Med Chem; 2006 Nov; 49(24):7182-9. PubMed ID: 17125270
[TBL] [Abstract][Full Text] [Related]
27. Resveratrol inhibits TCDD-induced expression of CYP1A1 and CYP1B1 and catechol estrogen-mediated oxidative DNA damage in cultured human mammary epithelial cells.
Chen ZH; Hurh YJ; Na HK; Kim JH; Chun YJ; Kim DH; Kang KS; Cho MH; Surh YJ
Carcinogenesis; 2004 Oct; 25(10):2005-13. PubMed ID: 15142886
[TBL] [Abstract][Full Text] [Related]
28. Resveratrol as an anti-cancer agent: A review.
Rauf A; Imran M; Butt MS; Nadeem M; Peters DG; Mubarak MS
Crit Rev Food Sci Nutr; 2018 Jun; 58(9):1428-1447. PubMed ID: 28001084
[TBL] [Abstract][Full Text] [Related]
29. Chemopreventive agent resveratrol, a natural product derived from grapes, reversibly inhibits progression through S and G2 phases of the cell cycle in U937 cells.
Park JW; Choi YJ; Jang MA; Lee YS; Jun DY; Suh SI; Baek WK; Suh MH; Jin IN; Kwon TK
Cancer Lett; 2001 Feb; 163(1):43-9. PubMed ID: 11163107
[TBL] [Abstract][Full Text] [Related]
30. Molecular analysis on the chemopreventive properties of resveratrol, a plant polyphenol microcomponent.
Latruffe N; Delmas D; Jannin B; Cherkaoui Malki M; Passilly-Degrace P; Berlot JP
Int J Mol Med; 2002 Dec; 10(6):755-60. PubMed ID: 12430003
[TBL] [Abstract][Full Text] [Related]
31. Resveratrol suppresses TPA-induced matrix metalloproteinase-9 expression through the inhibition of MAPK pathways in oral cancer cells.
Lin FY; Hsieh YH; Yang SF; Chen CT; Tang CH; Chou MY; Chuang YT; Lin CW; Chen MK
J Oral Pathol Med; 2015 Oct; 44(9):699-706. PubMed ID: 25401496
[TBL] [Abstract][Full Text] [Related]
32. Resveratrol suppresses oxidative stress and inflammatory response in diethylnitrosamine-initiated rat hepatocarcinogenesis.
Bishayee A; Barnes KF; Bhatia D; Darvesh AS; Carroll RT
Cancer Prev Res (Phila); 2010 Jun; 3(6):753-63. PubMed ID: 20501860
[TBL] [Abstract][Full Text] [Related]
33. Fighting cancer with red wine? Molecular mechanisms of resveratrol.
Kraft TE; Parisotto D; Schempp C; Efferth T
Crit Rev Food Sci Nutr; 2009 Oct; 49(9):782-99. PubMed ID: 20443159
[TBL] [Abstract][Full Text] [Related]
34. trans-3,4,5'-Trihydroxystibene inhibits hypoxia-inducible factor 1alpha and vascular endothelial growth factor expression in human ovarian cancer cells.
Cao Z; Fang J; Xia C; Shi X; Jiang BH
Clin Cancer Res; 2004 Aug; 10(15):5253-63. PubMed ID: 15297429
[TBL] [Abstract][Full Text] [Related]
35. The anticancer effects of resveratrol: modulation of transcription factors.
Whitlock NC; Baek SJ
Nutr Cancer; 2012; 64(4):493-502. PubMed ID: 22482424
[TBL] [Abstract][Full Text] [Related]
36. Involvement of p21WAF1/CIP1, pRB, Bax and NF-kappaB in induction of growth arrest and apoptosis by resveratrol in human lung carcinoma A549 cells.
Kim YA; Lee WH; Choi TH; Rhee SH; Park KY; Choi YH
Int J Oncol; 2003 Oct; 23(4):1143-9. PubMed ID: 12963997
[TBL] [Abstract][Full Text] [Related]
37. Resveratrol-induced apoptosis in MCF-7 human breast cancer cells involves a caspase-independent mechanism with downregulation of Bcl-2 and NF-kappaB.
Pozo-Guisado E; Merino JM; Mulero-Navarro S; Lorenzo-Benayas MJ; Centeno F; Alvarez-Barrientos A; Fernandez-Salguero PM
Int J Cancer; 2005 May; 115(1):74-84. PubMed ID: 15688415
[TBL] [Abstract][Full Text] [Related]
38. Involvement of the retinoblastoma (pRb)-E2F/DP pathway during antiproliferative effects of resveratrol in human epidermoid carcinoma (A431) cells.
Adhami VM; Afaq F; Ahmad N
Biochem Biophys Res Commun; 2001 Nov; 288(3):579-85. PubMed ID: 11676482
[TBL] [Abstract][Full Text] [Related]
39. Potential cancer-chemopreventive activities of wine stilbenoids and flavans extracted from grape (Vitis vinifera) cell cultures.
Waffo-Téguo P; Hawthorne ME; Cuendet M; Mérillon JM; Kinghorn AD; Pezzuto JM; Mehta RG
Nutr Cancer; 2001; 40(2):173-9. PubMed ID: 11962253
[TBL] [Abstract][Full Text] [Related]
40. Resveratrol causes Cdc2-tyr15 phosphorylation via ATM/ATR-Chk1/2-Cdc25C pathway as a central mechanism for S phase arrest in human ovarian carcinoma Ovcar-3 cells.
Tyagi A; Singh RP; Agarwal C; Siriwardana S; Sclafani RA; Agarwal R
Carcinogenesis; 2005 Nov; 26(11):1978-87. PubMed ID: 15975956
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
